CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Cash flows from operating activities
Net earnings	$ 10,962,000	$ 6,278,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	1,108,000	989,000
Amortization	343,000	335,000
Deferred taxes	(221,000)	(613,000)
Premium amortization, net of discount accretion	1,056,000	912,000
Gain on sale of loans	(1,398,000)	(1,189,000)
Provision for credit losses	0	1,400,000
Origination of loans held for sale	(32,850,000)	(25,017,000)
Proceeds from loans held for sale	35,127,000	24,550,000
Write-down of other real estate and repossessed assets	2,000	102,000
Net gain on sale of premises, equipment, other real estate owned and other assets	(50,000)	(2,000)
Stock based compensation	162,000	155,000
Net change in accrued interest receivable and other assets	(7,406,000)	1,775,000
Net change in accrued interest payable and other liabilities	3,049,000	(45,000)
Net cash provided by operating activities	9,884,000	9,630,000
Securities available for sale:
Purchases	(50,604,000)	(19,551,000)
Proceeds from maturities and principal repayments	19,776,000	10,142,000
Securities held to maturity:
Proceeds from maturities and principal repayments	0	3,024,000
Net originations of loans	(45,685,000)	(12,194,000)
Purchases of premises and equipment	(799,000)	(2,054,000)
Proceeds from BOLI death benefit	464,000	0
Proceeds from sale of premises, equipment, other real estate owned and other assets	115,000	177,000
Net cash used in investing activities	(76,733,000)	(20,456,000)
Cash flows from financing activities
Net change in deposits	188,820,000	43,622,000
Net change in securities sold under agreements to repurchase	8,376,000	743,000
Proceeds from FHLB advances	40,000,000	60,000,000
Repayment of FHLB advances	(100,005,000)	(44,504,000)
Proceeds from line of credit	3,000,000	20,000,000
Purchase of treasury stock	0	(10,817,000)
Exercise of stock options	527,000	72,000
Cash dividends	(2,188,000)	(2,076,000)
Net cash provided by financing activities	138,530,000	67,040,000
Net change in cash and cash equivalents	71,681,000	56,214,000
Cash and cash equivalents at beginning of period	351,791,000	90,714,000	$ 90,714,000
Cash and cash equivalents at end of period	423,472,000	146,928,000	$ 351,791,000
Supplemental disclosures of cash flow information
Interest paid	2,067,000	4,915,000
Supplemental schedule of noncash investing and financing activities
Cash dividends accrued	2,411,000	2,119,000
Transfer of loans to other real estate owned and repossessed assets	437,000	179,000
Stock dividend	$ 35,947,000	$ 0